PDGFRA D842V
|
GIST
|
PDGFRA D842V
|
GIST
|
avapritinib Sensitive: A1 - Approval
|
avapritinib Sensitive: A1 - Approval
|
PDGFRA D842V
|
GIST
|
PDGFRA D842V
|
GIST
|
dasatinib Sensitive: A2 - Guideline
|
dasatinib Sensitive: A2 - Guideline
|
PDGFRA D842V
|
Gastric Cancer
|
PDGFRA D842V
|
Gastric Cancer
|
imatinib Resistant: A2 - Guideline
|
imatinib Resistant: A2 - Guideline
|
PDGFRA D842V
|
GIST
|
PDGFRA D842V
|
GIST
|
ARO-002 Sensitive: C2 – Inclusion Criteria
|
ARO-002 Sensitive: C2 – Inclusion Criteria
|
PDGFRA D842V
|
GIST
|
PDGFRA D842V
|
GIST
|
sunitinib Resistant: C3 – Early Trials
|
sunitinib Resistant: C3 – Early Trials
|
PDGFRA D842V
|
GIST
|
PDGFRA D842V
|
GIST
|
imatinib Resistant: C3 – Early Trials
|
imatinib Resistant: C3 – Early Trials
|